Field evaluation and future applications of the world's first malaria vaccine

Abstract

This paper describes the safety, efficacy and operability of the world's first malaria vaccine (RTS, S/AS01) in latest field pilot studies and the recommendations from the WHO expert group for its use. In addition, further studies to examine the associations of inoculation rate and full-dose rate with the reduction in morbidity and mortality of malaria among target children and explore the scientific evidence for seasonable preventive vaccination with 5 doses and more among children at ages of below 5 years are recommended.